(Press-News.org) New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers, in collaboration with Tempero and GlaxoSmithKlein.
In a study reported online April 17, 2014 in the journal Immunity, the scientists combined drug screening with state-of-the-art techniques for analyzing the genome, leading to three small molecules that improved symptoms in a mouse form of multiple sclerosis.
The three potential drug candidates, selected from a large library of screened chemicals, each knocked down the response of Th17 cells, a type of immune cell that drives many autoimmune diseases by attacking normal cells in the body. More specifically, the drugs homed in on an essential molecule within the Th17 cells.
"We examined what makes Th17 cells – which play a crucial role in multiple autoimmune diseases – distinct from other closely related T cells within the immune system," said Alexander Marson, MD, PhD, a leading T cell expert and member of the UCSF Diabetes Center. "Then we investigated several small molecules that inhibit the development and function of these cells. When the Th17 cells were hit by these molecules we saw less severe multiple-sclerosis-like symptoms in the mice."
The research team, led by Marson and Vijay K. Kuchroo, PhD, an immunologist at Brigham and Women's Hospital in Boston and Harvard Medical School, combined powerful techniques to shed light on a class of protein molecules within cells known as transcription factors.
Drug designers have rarely targeted transcription factors. Each transcription factor binds to DNA at a unique set of locations along the 23 pairs of chromosomes, and thereby influences which genes are turned on and off to trigger the protein production that drives cell development and function.
Different transcription factors shape the development of different types of T cells within the immune system, Marson and others are discovering. In their new study, Marson found that the transcription factor called ROR gamma t has a unique role in guiding development of Th17 cells, while inhibiting the development of other immune cells.
Preventing Th17 cells from developing by inhibiting the function of ROR gamma t appears to be an effective strategy for fighting autoimmune diseases, Marson said.
"There already are drugs in clinical trials for autoimmune diseases – including psoriasis and rheumatoid arthritis – that are antibodies for IL-17 or IL-17 receptors," Marson said, referring to signaling molecules secreted by Th17 cells that can help trigger an attack our own healthy tissue, and the receptors that receive those signals. "This is an entirely different and promising approach to fight autoimmune disease," he said.
"Our studies map a path to targeting transcription factors and provide both insight into how transcriptional regulators shape the identity and affect the development of Th17 cells, and also into how different drug molecules might affect these regulatory circuits in the cells," he said.
To reveal the distinct and sometimes subtle effects of the drug candidates, the researchers studied the entire genome to see where ROR gamma t attached to DNA, which genes were activated or turned off as a result, and how these effects were altered by the drug candidates.
"Not only did we look at which genes are turned on and off, but we also systematically looked at DNA-binding sites across this genome," Marson said. "This pushes the boundary of what's typically done."
In addition to attaching to DNA, ROR gamma t has a pocket that looks like it should bind a hormone, Marson said. But what this hormone might be, and its effects, are unknown. The different drug candidates that inhibited Th17 development had different effects on ROR gamma t and resultant DNA binding and gene activation, possibly because of distinct interactions with the hormone-binding pocket, Marson said.
Analyzing the large data sets generated through such experiments could help pharmaceutical companies wading into development of drugs that target transcription factors to test the waters, Marson said, enabling drug developers to better understand mechanisms of drug action and to more easily see gene activity that could trigger side effects.
According to Marson, "This is a new, broadly applicable approach for systematically evaluating leading drug candidates for autoimmune diseases."
INFORMATION:
The National Multiple Sclerosis Society and the National Institutes of Health provided major funding for the research.
UCSF is the nation's leading university exclusively focused on health. Now celebrating the 150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with world-renowned programs in the biological sciences, a preeminent biomedical research enterprise and two top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco. Please visit http://www.ucsf.edu.
Autoimmune diseases may succumb to new drug strategy
UCSF/Harvard genome study identifies three possible drug candidates for multiple diseases
2014-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Maternal deaths on the rise in the United States
2014-05-02
SEATTLE — The United States is among just eight countries in the world to experience an increase in maternal mortality since 2003 – joining Afghanistan and countries in Africa and Central America, according to a new study by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
The study, "Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013," published May 2 in The Lancet, ranked the United States number 60 in the list of 180 countries ...
Sharp decline in maternal and child deaths globally, new data show
2014-05-02
SEATTLE — Since the start of an international effort to address maternal and child mortality, millions of lives have been saved globally, two new studies by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington show.
In 2000, the Millennium Development Goals (MDGs) were established by the United Nations to drive maternal and child deaths down by 2015. Child and maternal deaths had been falling in most countries since the 1980s, but the pace accelerated after the goals were set. If countries continue on this course, child deaths will fall ...
High quality 3-dimensional nanoporous graphene
2014-05-02
Sendai, Japan -- Three-dimentional (3D) nanoporous graphene with preserved 2D Dirac electronic characters was successfully synthesized by Dr. Yoshikazu Ito and Prof. Mingwei CHEN at Advanced Institute for Materials Research (AIMR), Tohoku University. The nanoporous graphene is constructed by a single layer graphene sheet that is continuously inter-connected to form a complex 3D network structure. This free-standing nanoporous graphene with an excellent crystallinity possesses high mobility, holding great promise for the applications in electronic devices.
The nanoporous ...
New atom-scale knowledge on the function of biological photosensors
2014-05-02
The research groups of Janne Ihalainen (University of Jyväskylä) and Sebastian Westenhoff (University of Gothenburg) have clarified how the atom structure of bacterial red light photosensors changes when sensing light. The research reveals structural changes in phytochrome protein when illuminated.
"The results are a unique demonstration of proteins' ability to structural changes in different phases of their operation. This helps to understand how the biological photosensors function. The modelling and utilisation of protein for other applications becomes much easier ...
Small variations in genetic code can team up to have a bi
2014-05-02
Scientists at USC have definitively demonstrated that large sets of variations in the genetic code that do not individually appear to have much effect can collectively produce significant changes in an organism's physical characteristics.
Studying the budding yeast Saccharomyces cerevisiae, USC's Matthew B. Taylor and Ian M. Ehrenreich found that the effects of these genetic variants can depend on four or more other variants in an individual's genome.
Most genetic analyses of heritable physical characteristics, including genome-wide association studies in human populations, ...
New myeloma-obesity research shows drugs can team with body's defenses
2014-05-02
Obesity increases the risk of myeloma, a cancer of plasma cells that accumulate inside the bones.
And with current obesity trends in the United States and especially in South Texas, that's ominous.
"I'm predicting an increase in multiple myeloma," said Edward Medina, M.D., Ph.D., "and with the obesity problems we see in the Hispanic population, there could be a serious health disparity on the horizon."
Dr. Medina, a hematopathologist and assistant professor in the Department of Pathology at The University of Texas Health Science Center at San Antonio, is looking ...
AGA unveils latest advances in GI research at DDW 2014
2014-05-02
Chicago, IL (May 2, 2014) — International leaders in the fields of gastroenterology and hepatology will gather together for Digestive Disease Week® (DDW) 2014, the largest and most prestigious gastroenterology meeting, from May 3 to 6, 2014, at McCormick Place in Chicago, IL. DDW is jointly sponsored by the American Gastroenterological Association (AGA) Institute, the American Association for the Study of Liver Diseases (AASLD), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT).
AGA researchers will present ...
Nature's chemical diversity reflected in Swedish lakes
2014-05-02
It's not only the biology of lakes that varies with the climate and other environmental factors, it's also their chemistry. More knowledge about this is needed to understand the ecology of lakes and their role in the carbon cycle and the climate. Today an international research group led by Uppsala University is publishing a comprehensive study of the composition of organic compounds in the prestigious journal Nature Communications.
- Lake water is like a very thin broth with several thousand ingredients in the recipe, all with different properties. At the same time ...
Stimulated mutual annihilation
2014-05-01
Twenty years ago, Philip Platzman and Allen Mills, Jr. at Bell Laboratories proposed that a gamma-ray laser could be made from a Bose-Einstein condensate (BEC) of positronium, the simplest atom made of both matter and antimatter (1). That was a year before a BEC of any kind of atom was available in any laboratory. Today, BECs have been made of 13 different elements, four of which are available in laboratories of the Joint Quantum Institute (JQI) (2), and JQI theorists have turned their attention to prospects for a positronium gamma-ray laser.
In a study published ...
Syracuse University physicists confirm existence of new type of meson
2014-05-01
Physicists in the College of Arts and Sciences at Syracuse University have made several important discoveries regarding the basic structure of mesons—subatomic particles long thought to be composed of one quark and one antiquark and bound together by a strong interaction.
Recently, Professor Tomasz Skwarnicki and a team of researchers proved the existence of a meson named Z(4430), with two quarks and two antiquarks, using data from the Large Hadron Collidor beauty (LHCb) Collaboration at CERN in Geneva, Switzerland. This tetraquark state was first discovered in Japan ...
LAST 30 PRESS RELEASES:
Being physically active, even just a couple of days a week, may be key to better health
High-fat diet promote breast cancer metastasis in animal models
A router for photons
Nurses and AI collaborate to save lives, reduce hospital stays
Multi-resistance in bacteria predicted by AI model
Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection
Sensing sickness
Cost to build multifamily housing in California more than twice as high as in Texas
Program takes aim at drinking, unsafe sex, and sexual assault on college campuses
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
[Press-News.org] Autoimmune diseases may succumb to new drug strategyUCSF/Harvard genome study identifies three possible drug candidates for multiple diseases